PALATIN TECHNOLOGIES, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
PALATIN TECHNOLOGIES, INC. (PTN) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $7.60 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-09-30 was -$1.29M.
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-09-30 was -$7.14M.
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-09-30 was -$2.46M.
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-09-30 was -$8.75M.
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$6.96M, a 552.79% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $1.54M.
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$21.95M.
- PALATIN TECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$30.17M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-03-31 | $7.60M 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $11.91M 10-Q · filed 2026-02-17 | |||
| 2025-09-30 | -$1.29M 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$6.96M 10-K · filed 2025-09-23 | |||
| 2025-03-31 | -$7.01M 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$6.11M 10-Q · filed 2026-02-17 | |||
| 2024-09-30 | -$7.14M 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $1.54M 10-K · filed 2025-09-23 | |||
| 2024-03-31 | $2.02M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $1.50M 10-Q · filed 2025-02-13 | |||
| 2023-09-30 | -$2.46M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$21.95M 10-K · filed 2024-09-30 | |||
| 2023-03-31 | -$10.31M 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$8.76M 10-Q · filed 2024-02-14 | |||
| 2022-09-30 | -$8.75M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$30.17M 10-K · filed 2023-09-28 | |||
| 2022-03-31 | -$22.39M 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$12.78M 10-Q · filed 2023-02-14 | |||
| 2021-09-30 | -$6.68M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$22.75M 10-K · filed 2022-09-22 | |||
| 2021-03-31 | -$14.21M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | -$10.70M 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |